Solid Organ Malignancy After Pancreas Transplantation: A Four Decade Single‐Center Experience
Solid organ malignancies constitute a substantial late complication in pancreas transplant recipients, with corticosteroid exposure and graft longevity as key risk factors. These findings underscore the need for long-term cancer surveillance and tailored immunosuppressive strategies in this population.
Authors
- Karthik Ramanathan
- Xianghua Luo (ORCID: https://orcid.org/0000-0001-7501-6582)
- Joseph Sushil Rao (ORCID: https://orcid.org/0000-0002-0197-6107)
- Michael W. Dryden
- Erik B. Finger (ORCID: https://orcid.org/0000-0003-3899-6985)
- Raja Kandaswamy (ORCID: https://orcid.org/0000-0003-4302-0119)
- Todd E. DeFor (ORCID: https://orcid.org/0000-0003-4667-0176)
- David V. Mathews
- Abraham J. Matar (ORCID: https://orcid.org/0000-0001-7351-7674)
- Matthew Wright
- Michael G. Megaly (ORCID: https://orcid.org/0009-0003-1198-6610)
- Vanessa Humpreville
Institutions
- University of Minnesota (US)
Publication Details
- Journal
- Clinical Transplantation
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1111/ctr.70381
- Primary Topic
- Viral-associated cancers and disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00